UNSPSC 51286704: Metioprim

This classification denotes an antibiotic with the molecular formula C14H18N4O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K29KWU39J0, chemically known as 2,4-pyrimidinediamine, 5-((3,5-dimethoxy-4-(methylthio)phenyl)methyl)- but more generally known as metioprim, which bears US NIH Compound Identifier 68590. European Medicines Agency schedules Metioprim in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08889MIG.

The term METIOPRIM is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 34, No. 10 1980, List 20). METIOPRIM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: S(C1C(OC)CC(CC2C(NC(NC2)N)N)CC1OC)C.

UNSPSC 51286704 Metioprim is a Commodity code under which state and local governments procure pharmaceutical products and medical supplies for public health and community health initiatives. Recent activity shows state and local agencies buying naloxone, drug deactivation systems, and antibiotic pharmaceuticals through competitive bidding and cooperative purchasing vehicles. The Illinois Department of Public Health and Seminole County, Florida represent the issuing-body mix, indicating procurement activity across state health departments and county health authorities. These jurisdictions use Invitation for Bid (IFB) processes and piggyback contracts through multistate cooperative purchasing consortia such as MMCAP to acquire pharmaceutical inventory for emergency response, disease prevention, and public health programs.

The code shows recent activity in Illinois and Florida. A representative opportunity is the Illinois Department of Public Health's August 28, 2026 piggyback pharmaceutical warehouse order through the MMCAP Infuse consortium (Solicitation 26482DPHPREPDB53392), which awarded $2,999,999.11 over a three-year term including renewals to Chartwell Rx LLC for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets. A second example is Seminole County, Florida's June 30, 2026 IFB (IFB60459723LAS) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, awarded on a fixed-fee basis with a two-year initial term and one-year renewal option. Both procurements require vendor compliance with drug-free workplace certification, E-Verify, insurance coverage standards, and applicable federal regulations when FEMA funding is involved.